A novel bioavailable hydrogenated curcuminoids formulation (CuroWhite™) improves symptoms and diagnostic indicators in rheumatoid arthritis patients - A randomized, double blind and placebo controlled study

Rheumatoid arthritis (RA) is an inflammatory disease that cause chronic pain, disability and joint destruction. The present placebo controlled randomized study aimed to evaluate the efficacy of a novel hydrogenated curcuminoid formulation-CuroWhite™, in rheumatoid arthritis (RA) patients. Twenty fou...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Joby, Amalraj, Augustine, Raj, K.K. Jithin, Divya, Chandradhara, Kunnumakkara, Ajaikumar B., Gopi, Sreeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702143/
https://www.ncbi.nlm.nih.gov/pubmed/31453131
http://dx.doi.org/10.1016/j.jtcme.2018.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702143/
https://www.ncbi.nlm.nih.gov/pubmed/31453131
http://dx.doi.org/10.1016/j.jtcme.2018.06.001

Ejemplares similares